Saratov JOURNAL of Medical and Scientific Research

PRP-therapy efficiency analysis for various shoulder tendinopathies

Year: 2019, volume 15 Issue: №3 Pages: 648-653
Heading: Traumatology and Orthopedics Article type: Original article
Authors: Norkin A.I., Malanin D.A., Tregubov A.S., Demeshchenko M.V., Cherezov L.L., Shormanov A.M., Emkuzhev O.L., Anisimova E.A.
Organization: Saratov State Medical University, Volgograd Medical Scientific Center, Volgograd State Medical University

Objective: to perform comparative analysis of PRP-therapy efficiency in patients with various shoulder tendinopathies. Material and Methods. 122 patients with rotator cuff tendinopathies (66%), subacromial impingements and rotator cuff tendinopathies (16%), CLB tendon tendinopathies (18%) participated in the research. The diagnostic scales for estimation of pain syndrome and shoulder joint function, as well as ultrasound and MRT examinations were employed to assess the outcomes in 1 and 6 months after PRP-therapy. Results. Patients of all groups had significant improvements by scales compared to their condition at the beginning of PRP-therapy. The positive response obtained in one month after the treatment still subsisted in 6 months. The most impressive responses to treatment were observed in patients with rotator cuff and CLB tendinopathies (strong middle effect 0.8-0.88). The patients of these groups self-estimated their outcomes relatively high. The scores defining outcomes were somewhat lower in the group of patients with both rotator cuff tendinopathies and subacromial impingements. Both MRT and ultrasound examinations revealed improvements in shoulder joint structures: edema reduction and dissipation, hypoechoic signal areas. Conclusion. PRP-therapy at shoulder tendinopathies may be referred to safe effective biological methods of treatment.

1 Zhang J, Wang JH-C. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Amer J Sports Med 2010; 38 (12): 2477-86.
2 Kaux JF, Drion P, Croisier JL, et al. Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use. J Stem Cells and Regenerative Medicine 2015; 11 (1): 7-17.
3 Filardo G, Di Matteo B.Kon E, et al. Platelet-rich plasma in tendon-related disorders: results and indication. Knee Surg Sports Traumatol Arthrosc 2018; 26: 1984-99.
4 Kaux J-F, Forthomme B, Goff CL, et al. Current opinions on tendinopathy. J Sports Science and Medicine 2011; 10:238-53.
5 Kesikburun S, Tan AK, Yilmaz B, et al. Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1 -year follow-up. Amer J Sports Med 2013; 41 (11): 2609-16.
6 Rha DW, Park CY, Kim YK, et al. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil 2013; 27 (2): 113-22.
7 Von Wehren L, Fabian Blanke F, Todorov A, et al. The effect of subacromial injections of autologous conditioned plasma versus cortisone for the treatment of symptomatic partial rotator cuff tears. Knee Surg Sports Traumatol Arthrosc 2016; 24: 3787-92.
8 Dolkart O, Chechik O, Zarfati Y, et al. Single dose of platelet-rich plasma improves the organization and strength of a surgically repaired rotator cuff tendon in rats. Arch Orthop Trauma Surg 2014; 134(9): 1271-7.
9 Scarpone M, Rabago D, Snell E, et al. Effectiveness of platelet-rich plasma injection for rotator cuff tendinopathy: A prospective open-label study. GlobAdv Health Med 2013; 2 (2): 26-31.
10 Tsicopoluos K, Tsicopoluos I, Simeonidis E, et al. The clinical impact of platelet-rich plasma on tendinopathy compared to placebo or dry needling injections: a meta-analysis. PhysTher Sports 2016; 17:87-94.
11 Foster ТЕ, PuskasBL, Mandelbaum BR, etal. Platelet-rich plasma: from basic science to clinical applications. Amer J Sports Med 2009; 37 (11): 2259-72.
12 Werner RA, Franzblau A, Gell N, et al. A longitudinal study of industrial and clerical workers: predictors of upper extremity tendonitis. Journal of Occupational Rehabilitation 2005; 15:37-46.
13 Maffulli N, Wong J, Almekinders LC. Types and epidemiology of tendinopathy. Clinics in Sports Medicine 2003; 22: 675-92.
14 Sharma P, Maffulli N. Biology of tendon injury: healing, modeling and remodeling. J Musculoskelet Neuronal Interact 2006; 6 (2): 181-90.
15 Riley GP, Curry V, DeGroot J, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002; 21: 185-95.
16 GoodshipAE, Birch HL, Wilson AM. The pathobiology and repair of tendon and ligament injury. Vet Clin North Amer Equine Pract 1994; 10: 323-49.
17 Yuan J, Wang MX, Murrell GA. Cell death and tendinopathy. Clin Sports Med 2003; 22: 693-701.
18 Bestwick CS, Maffulli N. Reactive oxygen species and tendon problems: review and hypothesis. Sports Med Arthroscopy Rev 2000; 8: 6-16.
19 Jozsa L, Kannus P. Human Tendon: anatomy, physiology and pathology. Human Kinetics, Champaign, USA, 1997
20 Khan KM, Cook JL, Bonar F, et al. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 1999; 27: 393-408.

2019_03_648-653.pdf337.95 KB

No votes yet